HTG Molecular Diagnostics, Inc. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
HTG Molecular Diagnostics, Inc. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $38.79 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-05-10
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-03-31 was $38.79M.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-12-31 was $4.24M, a 1647.98% increase year-over-year.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was $176.29K.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $13.07M.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $15.75M, a 677.71% increase from fiscal 2016.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $2.03M, a 96.04% decline from fiscal 2015.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $51.11M, a 226.52% increase from fiscal 2014.
- HTG Molecular Diagnostics, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $15.65M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | $38.79M 10-Q · filed 2018-05-10 | $43.03M derived: sum of 2 quarters · filed 2018-05-10 | $43.21M derived: sum of 3 quarters · filed 2018-05-10 | $56.28M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $4.42M derived: sum of 2 quarters · filed 2018-03-23 | $17.49M derived: sum of 3 quarters · filed 2018-03-23 | $15.75M 10-K · filed 2018-03-23 |
| 2017-09-30 | $176.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $13.25M derived: sum of 2 quarters · filed 2017-11-07 | $11.51M 10-Q · filed 2017-11-07 | $11.75M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $13.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $11.34M 10-Q · filed 2017-08-08 | $11.58M derived: sum of 3 quarters · filed 2018-05-10 | $9.91M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | -$1.74M 10-Q · filed 2018-05-10 | -$1.50M derived: sum of 2 quarters · filed 2018-05-10 | -$3.16M derived: sum of 3 quarters · filed 2018-05-10 | -$4.69M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $242.66K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -$1.42M derived: sum of 2 quarters · filed 2018-03-23 | -$2.95M derived: sum of 3 quarters · filed 2018-03-23 | $2.03M 10-K · filed 2018-03-23 |
| 2016-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$3.19M derived: sum of 2 quarters · filed 2017-11-07 | $1.78M 10-Q · filed 2017-11-07 | $1.80M derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $3.45M 10-Q · filed 2017-08-08 | $3.46M derived: sum of 3 quarters · filed 2017-08-08 | $3.48M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $4.97M 10-Q · filed 2017-05-15 | $4.99M derived: sum of 2 quarters · filed 2017-05-15 | $5.00M derived: sum of 3 quarters · filed 2017-05-15 | $53.37M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $13.52K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $31.76K derived: sum of 2 quarters · filed 2017-03-23 | $48.40M derived: sum of 3 quarters · filed 2017-03-23 | $51.11M 10-K · filed 2017-03-23 |
| 2015-09-30 | $18.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $48.39M derived: sum of 2 quarters · filed 2016-11-14 | $51.10M 10-Q · filed 2016-11-14 | $50.04M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $48.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $51.08M 10-Q · filed 2016-08-09 | $50.02M derived: sum of 3 quarters · filed 2016-08-09 | $58.82M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $2.71M 10-Q · filed 2016-05-12 | $1.65M derived: sum of 2 quarters · filed 2016-05-12 | $10.45M derived: sum of 3 quarters · filed 2016-05-12 | $10.20M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $7.74M derived: sum of 2 quarters · filed 2016-03-25 | $7.49M derived: sum of 3 quarters · filed 2016-03-25 | $15.65M 10-K · filed 2016-03-25 |
| 2014-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $8.54M derived: sum of 2 quarters · filed 2015-11-12 | $16.71M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$255.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $7.91M 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $8.17M 10-Q · filed 2015-06-08 |